Sharism- Lifestyle
Author:
Theriva Biologics, Inc.
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
May 7, 2026
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
April 17, 2026
Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting with U.S. FDA Regarding the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma
March 23, 2026
Theriva™ Biologics Reports Full-Year 2025 Operational Highlights and Financial Results
March 12, 2026